Evidence map›Paper›PMID 26946144›Full record

ArticleCytotechnology2016

The effect of a number of H9C2 rat cardiomyocytes passage on repeatability of cytotoxicity study results.

Piotr Witek, Agnieszka Korga, Franciszek Burdan, Marta Ostrowska, Beata Nosowska, Magdalena Iwan, Jarosław Dudka

Abstract read
In one paragraph

Article in Cytotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Therapeutic Potential ofCardiovascular & hematological agents in medicinal chemistry · 2024
    Article
  8. Article
  9. Article
  10. Cardioprotective Role ofCardiovascular & hematological agents in medicinal chemistry · 2024
    Article
  11. Cardioprotective Effect ofMolecules (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Piotr WitekIndependent Medical Biology Unit, Medical University of Lublin, Chodzki 6, 20-093, Lublin, Poland.
Agnieszka KorgaIndependent Medical Biology Unit, Medical University of Lublin, Chodzki 6, 20-093, Lublin, Poland. agnieszka.korga@umlub.pl.
Franciszek BurdanDepartment of Human Anatomy, Medical University of Lublin, Jaczewskiego 4, 20-090, Lublin, Poland.
Marta OstrowskaIndependent Medical Biology Unit, Medical University of Lublin, Chodzki 6, 20-093, Lublin, Poland.
Beata NosowskaIndependent Medical Biology Unit, Medical University of Lublin, Chodzki 6, 20-093, Lublin, Poland.
Magdalena IwanIndependent Medical Biology Unit, Medical University of Lublin, Chodzki 6, 20-093, Lublin, Poland.
Jarosław DudkaIndependent Medical Biology Unit, Medical University of Lublin, Chodzki 6, 20-093, Lublin, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The embryonic cardiomyocyte cell line H9C2 is commonly used in numerous in vitro studies, including cardiotoxicity analyses of new drugs. So far no results were published for studies on cell parameters variability during the cell line ageing process. For this reason the aim of the study was to evaluate the effect of a number of H9C2 rat embryonic cardiomyocytes passages on repeatability of study results for selected cytotoxicity parameters, with doxorubicin as a model toxic agent. The cultures were passaged twenty-five times. Cells from passage 1, 5, 10, 15, 20 and 25 were treated with doxorubicin for 24 h. Then drug cytotoxicity was evaluated with the MTT test and additionally the nuclear factor erythroid 2-related factor (Nrf2) gene expression was examined. The analysis of oxidative stress intensity and cell morphology was also assessed. The microscopic appearance of cells indicates that untreated cardiomyocytes morphology changes as well as sensitivity to toxic effects increases with the number of passages. Also an increase in oxidative stress in cells occurs with further passaging of cardiomyocytes. Statistical significance of differences in conducted tests results depended on doxorubicin concentration but in many cases the H9C2 line was found to be a reliable in vitro model only for the first five passages. For this reason it is important to take into consideration that further culturing of cardiomyocytes may not ensure repeatability of study results due to the culture ageing.

Indexed as

CytotoxicityH9C2 cell linePassage number

Identifiers

PMID26946144
PMCPMC5101311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.